coronary syndrome—were divided into 8 groups of study, consistent with lowresponse to clopidogrel and the type of coronaryarterydisease. … relation with the type of CAD and response to clopidogrel: group 1: STEMI ADPtest >46 U = 21 patients with STEMI and lowresponse to clopidogrel; group 2: STEMI ADPtest <46 U = 61 patients with STEMI normal responders to clopidogrel; group 3: NSTEMI ADPtest >46 U = 25 patients with NSTEMI and lowresponse to …
Abstract
Background:
In patients with coronary artery disease, cardiovascular mortality and other acute events showed a clear correlation with risk factors and biomarkers including platelet activation.